Nurse Support Program for Triple-Negative Breast Cancer
Part of Cancer, Skin clinical trials.
This study tests a nurse-led coping and support program for people who recently finished treatment for triple-negative breast cancer. The program is designed to help you manage stress and emotional distress after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with stage 1, 2, or 3 triple-negative breast cancer (not stage 4)
- You are at least 18 years old
- You finished curative (treatment meant to cure) therapy between 1 and 12 months ago
- You are experiencing at least moderate distress (4 or higher on a 0–10 scale)
- You can read and understand English or Spanish
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combination of radiation therapy and immunotherapy for people with advanced triple-negative breast cancer who haven't had chemotherapy for their advanced disease. It aims to see if adding radiation to standard chemotherapy can help shrink tumors and improve outcomes.
This trial tests a stronger post-surgery treatment to reduce the chance of breast cancer coming back in women with a certain type of triple-negative breast cancer (one that also has high androgen receptor activity). If you already had chemo before surgery but it didn't completely eliminate the cancer, this might be an option for you.
This trial tests a combination of chemotherapy, the immunotherapy drug pembrolizumab, and low or high-dose radiation before surgery for people with triple-negative breast cancer that has spread to the lymph nodes. The goal is to see if this approach can improve treatment outcomes.
This study tests whether a structured stress-reduction program can help people with newly diagnosed triple-negative breast cancer (stages I–III). The goal is to see if the program is practical and beneficial for patients during treatment.
This study looks at how your immune system responds to triple-negative breast cancer. It will test your blood or tissue to learn more about your body's natural defenses against the cancer.
This trial tests an experimental drug given during surgery to remove breast cancer. The goal is to see if it helps prevent the cancer from coming back in people with triple-negative breast cancer.
Hear when a new Triple Negative Breast Cancer (TNBC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.